CDNA CareDx, Inc Stock Quote

CDNA [NASD]

Healthcare | Diagnostics & Research | USA

Index	-	P/E	-	EPS (ttm)	-0.45	Insider Own	2.10%	Shs Outstand	49.01M	Perf Week	-2.78%
Market Cap	4.33B	Forward P/E	226.72	EPS next Y	0.38	Insider Trans	-19.28%	Shs Float	48.41M	Perf Month	11.17%
Income	-20.00M	PEG	-	EPS next Q	0.01	Inst Own	-	Short Float	9.69%	Perf Quarter	68.87%
Sales	169.40M	P/S	25.57	EPS this Y	60.30%	Inst Trans	0.17%	Short Ratio	6.88	Perf Half Y	162.96%
Book/sh	5.48	P/B	15.64	EPS next Y	136.25%	ROA	-7.90%	Target Price	78.50	Perf Year	295.48%
Cash/sh	4.23	P/C	20.26	EPS next 5Y	20.00%	ROE	-10.90%	52W Range	13.04 - 99.83	Perf YTD	18.29%
Dividend	-	P/FCF	250.36	EPS past 5Y	-52.30%	ROI	-22.80%	52W High	-15.02%	Beta	0.70
Dividend %	-	Quick Ratio	4.00	Sales past 5Y	36.00%	Gross Margin	66.40%	52W Low	550.61%	ATR	4.87
Employees	306	Current Ratio	4.10	Sales Q/Q	58.00%	Oper. Margin	-14.70%	RSI (14)	59.20	Volatility	6.31% 5.85%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-34.40%	Profit Margin	-11.80%	Rel Volume	0.52	Prev Close	85.70
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Oct 29 AMC	Payout	-	Avg Volume	681.78K	Price	84.84
Recom	1.50	SMA20	4.93%	SMA50	20.87%	SMA200	93.20%	Volume	44,481	Change	-1.00%

Oct-30-20

Reiterated

H.C. Wainwright

Buy

$47 → $55

Oct-08-20

Reiterated

H.C. Wainwright

Buy

$45 → $47

Oct-02-20

Reiterated

H.C. Wainwright

Buy

$40 → $45

Aug-05-20

Reiterated

H.C. Wainwright

Buy

$37 → $40

Jun-26-20

Initiated

BTIG Research

Buy

$40

Jun-19-20

Reiterated

H.C. Wainwright

Buy

$40 → $37

Oct-01-19

Resumed

Craig Hallum

Buy

$48

May-09-19

Upgrade

H.C. Wainwright

Neutral → Buy

$30 → $43

Feb-15-19

Initiated

Jefferies

Buy

$35

Oct-23-18

Resumed

Raymond James

Strong Buy

$30

Sep-18-18

Reiterated

H.C. Wainwright

Neutral

$17 → $22

Nov-27-17

Initiated

H.C. Wainwright

Buy

$12

Jun-14-16

Reiterated

Mizuho

Buy

$12 → $8

Sep-29-15

Downgrade

Raymond James

Outperform → Mkt Perform

Sep-25-15

Initiated

Craig Hallum

Buy

Mar-18-15

Reiterated

Mizuho

Buy

$15 → $12

Jan-25-21 04:28PM	CareDx Announces Closing of Public Offering of Common Stock GlobeNewswire
Jan-20-21 10:56PM	CareDx Announces Pricing of Public Offering of Common Stock GlobeNewswire
Jan-19-21 05:11PM	Quidel Flashes Improved Relative Price Strength Investor's Business Daily +5.88%
04:14PM	CareDx Announces Proposed Public Offering of Common Stock GlobeNewswire
11:19AM	Insider Sells CareDx's Shares Benzinga
Jan-11-21 07:00AM	CareDx Reports Preliminary Fourth Quarter and Full Year 2020 Results GlobeNewswire
Jan-08-21 07:01AM	CareDx Agrees to Acquire TransChart and Expands EMR Connectivity to Over 90 Centers GlobeNewswire +6.24%
07:00AM	CareDx Transplant Leadership Showcased at ASTS 2021 GlobeNewswire
Jan-07-21 07:00AM	CareDx Announces AlloID and Exclusive Partnership with IDbyDNA GlobeNewswire
Jan-04-21 07:00AM	CareDxs AlloSeq HCT Wins Tender for French Stem Cell Transplant Patient Surveillance GlobeNewswire
Dec-31-20 07:10AM	The Zacks Analyst Blog Highlights: MACOM Tech, CrowdStrike, Zscaler, CareDx and Medifast Zacks
Dec-30-20 12:00PM	Are You Looking for a Top Momentum Pick? Why CareDx (CDNA) is a Great Choice Zacks
08:53AM	5 Stocks With Unstoppable Growth to Buy in 2021 Zacks
Dec-23-20 07:29PM	12 Best Genomic Stocks to Buy Now Insider Monkey
Dec-22-20 09:59AM	CareDx Celebrates the Long-Awaited Passage of the Immuno Bill GlobeNewswire +6.61%
Dec-21-20 07:06AM	CareDx's (CDNA) Shares March Higher, Can It Continue? Zacks
Dec-18-20 11:22AM	Zacks Industry Outlook Highlights: Apollo Medical, bioMerieux, CareDx and Harrow Health Zacks
Dec-17-20 10:30AM	4 Top Medical Services Stocks to Beat COVID-19 Resurgence Crisis Zacks
Dec-14-20 12:00PM	CareDx (CDNA) is a Great Momentum Stock: Should You Buy? Zacks
Dec-01-20 07:00AM	CareDx Announces First AlloSure Pediatrics Publication GlobeNewswire
Nov-26-20 12:00PM	CareDx (CDNA) Is Up 12.28% in One Week: What You Should Know Zacks
Nov-25-20 07:00AM	CareDx to Participate in Upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference GlobeNewswire
Nov-17-20 05:00AM	CareDx Receives Medicare Reimbursement Pricing for AlloSure Heart GlobeNewswire +5.01%
Nov-14-20 08:00AM	Abbott Labs, Intuitive Surgical Headline 5 Top Stocks Near Buy Points Investor's Business Daily
Nov-10-20 07:00AM	CareDx to Participate at Upcoming Conferences GlobeNewswire
Nov-06-20 07:05AM	New Publication Shows CareDxs AlloSure May Be Effective for Monitoring BK Virus in Transplant Patients GlobeNewswire
07:00AM	CareDx Joins National Kidney Foundation in Virtual Walk for Kidney Patients GlobeNewswire
Oct-30-20 03:01PM	CareDx Inc (CDNA) Q3 2020 Earnings Call Transcript Motley Fool
Oct-29-20 06:45PM	CareDx (CDNA) Beats Q3 Earnings and Revenue Estimates Zacks
04:06PM	Peter Maag Appointed Executive Chairman of the Board of Directors of CareDx; Reginald Seeto Appointed President and CEO GlobeNewswire
04:05PM	CareDx Reports Third Quarter 2020 Results GlobeNewswire
03:00PM	CareDx, Inc.to Host Earnings Call ACCESSWIRE
Oct-22-20 12:34PM	CareDx (CDNA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release Zacks
Oct-21-20 11:23AM	Tenet Healthcare's (THC) Earnings Beat in Q3, Improve Y/Y Zacks
07:00AM	CareDx Showcases Leading Transplant Data at ASN 2020 GlobeNewswire
Oct-19-20 07:05AM	Medicare Proposes to Maintain Current Reimbursement Process for AlloMap GlobeNewswire
07:00AM	CareDx Leads in Innovation with AlloSeq Portfolio at ASHI 2020 GlobeNewswire
Oct-15-20 04:05PM	CareDx to Report Third Quarter 2020 Financial Results GlobeNewswire
Oct-12-20 12:00PM	Here's Why CareDx (CDNA) is a Great Momentum Stock to Buy Zacks
11:00AM	What's in the Offing for UnitedHealth (UNH) Earnings in Q3? Zacks
Oct-09-20 03:30AM	CareDx Soars 15% As 3Q Revenue Outlook Surpasses Estimates SmarterAnalyst +6.78%
Oct-08-20 04:21PM	IBM, CareDx: 5 Top Stock Gainers for Thursday TheStreet.com +15.21%
07:52AM	The Daily Biotech Pulse: Gilead, Lilly COVID-19 Treatment Supply Agreements, CareDx's Positive Preannouncement, Aziyo Biologics Debuts On Wall Street Benzinga
Oct-07-20 04:05PM	CareDx Reports Preliminary Third Quarter 2020 Revenue GlobeNewswire
12:47PM	Hedge Funds Are Coming Back To CareDx, Inc. (CDNA) Insider Monkey
Oct-02-20 07:35AM	The Daily Biotech Pulse: Mesoblast Slumps On FDA Rejection, AstraZeneca's Breakthrough Therapy Designation, 3 IPOs Benzinga
07:00AM	CareDx Announces Publication of Pivotal AlloSure Lung Data GlobeNewswire
Sep-24-20 07:00AM	CareDx Launches AlloCare at Virtual Transplant Festival GlobeNewswire
Sep-11-20 07:00AM	CareDx Shares Latest Clinical Data at the TTS 2020 Virtual Conference GlobeNewswire
Sep-10-20 07:00AM	CareDx Strengthens Leadership Team to Accelerate Growth GlobeNewswire
Sep-05-20 07:27AM	2 Mid-Cap Healthcare Stocks to Buy Now Motley Fool
Sep-02-20 07:00AM	CareDx to Participate at Upcoming Conferences GlobeNewswire
Aug-12-20 09:40AM	Did Hedge Funds Make The Right Call On CareDx, Inc. (CDNA)? Insider Monkey
Aug-05-20 07:11AM	How Does CareDx's (NASDAQ:CDNA) CEO Pay Compare With Company Performance? Simply Wall St. +5.51%
02:01AM	CareDx Inc (CDNA) Q2 2020 Earnings Call Transcript Motley Fool
Aug-04-20 07:45PM	CareDx (CDNA) Q2 Earnings and Revenues Surpass Estimates Zacks
04:05PM	CareDx Reports Second Quarter 2020 Results GlobeNewswire
Jul-30-20 07:00AM	CareDx to Participate at the Canaccord Genuity 40th Annual Growth Conference GlobeNewswire
Jul-24-20 10:20PM	3 Artificial Intelligence Stocks With Long-Term Narratives TipRanks
Jul-16-20 04:05PM	CareDx to Report Second Quarter 2020 Financial Results GlobeNewswire
Jul-15-20 07:00AM	CareDx Chairman and CEO Peter Maag to Present at Global Kidney Innovations Summit GlobeNewswire
Jun-29-20 01:29PM	Edited Transcript of CDNA earnings conference call or presentation 30-Apr-20 8:30pm GMT Thomson Reuters StreetEvents +8.35%
Jun-24-20 04:12PM	Hedge Funds Arent Crazy About CareDx, Inc. (CDNA) Anymore Insider Monkey
Jun-22-20 07:00AM	New Kidney360 Publication Highlights CareDxs AlloSure is Differentiated as the dd-cfDNA Test of Choice GlobeNewswire
Jun-18-20 04:05PM	CareDx Announces Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire
07:00AM	FDA Accepts Letter of Intent for iBox Scoring System as a Surrogate Endpoint in Pharmaceutical Clinical Trials GlobeNewswire
Jun-15-20 04:05PM	CareDx Announces Closing of Public Offering of Common Stock GlobeNewswire
Jun-10-20 08:12PM	CareDx Announces Pricing of Public Offering of Common Stock GlobeNewswire
Jun-09-20 05:13PM	CareDx Announces Proposed Public Offering of Common Stock GlobeNewswire
08:00AM	Seven Bridges Selected by CareDx to Advance Its Transplant Care Solutions PR Newswire
Jun-08-20 05:00PM	CareDx Announces 2020 Annual Meeting of Stockholders to be Held as a Virtual Meeting GlobeNewswire
Jun-04-20 07:00AM	CareDx to Participate at the Goldman Sachs Global Healthcare Conference GlobeNewswire
May-28-20 07:00AM	CareDx to Present at the Jefferies Virtual Healthcare Conference GlobeNewswire
May-27-20 07:00AM	CareDx Presents the Latest AlloSure Data in Virtual Meetings GlobeNewswire +5.60%
May-15-20 07:00AM	CareDx's AlloSeq Tx 17 Awarded CE Mark Approval GlobeNewswire +6.13%
May-14-20 08:15AM	CareDx and Veracyte Announce Exclusive Partnership for Transplant Rejection Testing on nCounter System Business Wire
May-07-20 07:00AM	CareDx Brings the Transplant Patient Community Together GlobeNewswire
May-05-20 07:00AM	CareDx Collaborates with Weill Cornell Medicine to Lead the Development and Commercialization of UroMap GlobeNewswire
May-02-20 08:35AM	Here's Why We're Not At All Concerned With CareDx's (NASDAQ:CDNA) Cash Burn Situation Simply Wall St.
May-01-20 01:00PM	CareDx Inc (CDNA) Q1 2020 Earnings Call Transcript Motley Fool +5.79%
Apr-30-20 04:05PM	CareDx Reports First Quarter 2020 Results GlobeNewswire -5.51%
Apr-27-20 07:00AM	CareDx Engages European Lab Community in Virtual Meetings GlobeNewswire
Apr-23-20 12:32PM	Earnings Preview: CareDx (CDNA) Q1 Earnings Expected to Decline Zacks
07:00AM	CareDx and Johns Hopkins Partner on AlloSure Lung Surveillance GlobeNewswire
Apr-22-20 07:00AM	CareDx Presents New Heart and Lung Transplant Data in Virtual Meetings GlobeNewswire
Apr-21-20 07:00AM	CareDx to Report First Quarter 2020 Financial Results GlobeNewswire
Apr-14-20 07:00AM	CareDx Introduces AlloCell: Cell Therapy Surveillance GlobeNewswire +7.54%
Apr-09-20 07:00AM	CareDx Mobilizes 10,000 Phlebotomists for Home Blood Draws of Transplant Patients with RemoTraC GlobeNewswire
Apr-08-20 04:01PM	CareDx Reports Preliminary First Quarter 2020 Revenue and Provides Business Update in Response to COVID-19 Pandemic GlobeNewswire +5.16%
Apr-06-20 07:00AM	CareDx Supports Launch of International COVID-19 Transplant Registry (C19TxR) GlobeNewswire +15.78%
Apr-02-20 06:44AM	Is There An Opportunity With CareDx, Inc's (NASDAQ:CDNA) 54% Undervaluation? Simply Wall St. +6.06%
Mar-25-20 12:46AM	Edited Transcript of CDNA earnings conference call or presentation 27-Feb-20 9:30pm GMT Thomson Reuters StreetEvents +13.21%
Mar-20-20 07:00AM	REPEAT - New AJT Publication: AlloSure Monitors First Patient Retransplanted After Anti-PD-L1 Cancer Therapy GlobeNewswire +6.97%
01:05AM	New AJT Publication: AlloSure Monitors First Patient Retransplanted After Anti-PD-L1 Cancer Therapy GlobeNewswire
Mar-17-20 10:10AM	Are Options Traders Betting on a Big Move in CareDx (CDNA) Stock? Zacks -6.36%
08:48AM	The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment Benzinga
07:00AM	CareDx Launches RemoTraC: Home-Based Monitoring of Transplant Patients GlobeNewswire
Mar-12-20 07:00AM	CareDx Joins National Kidney Foundation on World Kidney Day to Support Kidney Transplant Community GlobeNewswire -10.22%
Mar-05-20 07:00AM	CareDx Brings Personalized Care to Transplant with the Launch of KIRA Immuno-optimization Study at CEOT GlobeNewswire
Feb-28-20 07:00AM	CareDx to Participate in Upcoming Investor Conferences GlobeNewswire

CareDx, Inc. discovers, develops, and commercializes healthcare solutions for transplant patients and caregivers worldwide. It offers AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; and AlloMap Heart, a gene expression solution for heart transplant patients. The company also develops, manufactures, markets, and sells products that increase the chance of successful transplants by facilitating a match between a donor and a recipient of stem cells and solid organs. In addition, it offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; Olerup SBT, a product range for sequence-based typing of HLA alleles; QTYPE that enables precision in HLA typing at a low to intermediate resolution for samples that uses real-time polymerase chain reaction methodology; and TruSight HLA, a solution for use in transplantation diagnostic testing. Further, the company provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Ottr, a transplant patient tracking software; and XynQAPI and Waitlist Management solutions. It offers its products directly to customers, as well as through third-party distributors. The company has a license agreement with Illumina, Inc. for the development, commercialization, and distribution of sequencing product line for use in transplantation diagnostic testing; and Cibiltech SAS to commercialize KidneyCare iBox, a software for the predictive analysis of post-transplantation kidney allograft loss, as well as a partnership with IDbyDNA, Inc. for the development of metagenomic infectious disease testing. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. CareDx, Inc. was incorporated in 1998 and is headquartered in South San Francisco, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SNYDERMAN RALPH	Director	Jan 15	Sale	88.88	12,000	1,066,513	72,672	Jan 19 08:58 AM
King Sasha	Chief Commercial Officer	Jan 14	Option Exercise	9.20	9,875	90,866	53,306	Jan 15 05:21 PM
King Sasha	Chief Commercial Officer	Jan 14	Sale	87.55	9,875	864,591	43,431	Jan 15 05:21 PM
Cohen Fred E	Director	Jan 06	Option Exercise	14.74	15,000	221,100	105,893	Jan 06 08:37 PM
Maag Peter	Executive Chair	Jan 05	Option Exercise	6.31	10,000	63,100	431,974	Jan 06 06:01 PM
Maag Peter	Executive Chair	Jan 05	Sale	71.92	10,000	719,237	421,974	Jan 06 06:01 PM
Seeto Reginald	See Remarks	Dec 18	Sale	68.01	8,363	568,801	114,035	Dec 18 08:40 PM
Goldberg Michael	Director	Dec 14	Sale	70.19	30,000	2,105,722	57,404	Dec 14 07:57 PM
Bickerstaff George	Director	Dec 14	Sale	71.76	10,000	717,644	80,487	Dec 14 07:50 PM
Maag Peter	Executive Chair	Dec 07	Option Exercise	6.31	10,000	63,100	431,974	Dec 08 04:06 PM
Maag Peter	Executive Chair	Dec 07	Sale	66.37	10,000	663,667	421,974	Dec 08 04:06 PM
HAGSTROM WILLIAM A	Director	Nov 12	Option Exercise	6.50	10,000	65,000	28,575	Nov 13 04:08 PM
HAGSTROM WILLIAM A	Director	Nov 12	Sale	54.59	10,000	545,888	18,575	Nov 13 04:08 PM
Maag Peter	Executive Chair	Nov 05	Option Exercise	6.08	10,000	60,757	431,974	Nov 05 07:33 PM
Maag Peter	Executive Chair	Nov 05	Sale	53.48	10,000	534,791	421,974	Nov 05 07:33 PM
Bell Michael Brian	Chief Financial Officer	Nov 03	Option Exercise	16.75	25,640	429,549	135,917	Nov 03 07:42 PM
Bell Michael Brian	Chief Financial Officer	Nov 03	Sale	48.15	32,574	1,568,487	103,343	Nov 03 07:42 PM
King Sasha	Chief Commercial Officer	Oct 08	Option Exercise	9.38	25,779	241,732	84,206	Oct 09 05:03 PM
King Sasha	Chief Commercial Officer	Oct 08	Sale	50.62	40,775	2,064,210	43,431	Oct 09 05:03 PM
Maag Peter	Chief Executive Officer	Oct 05	Option Exercise	5.90	10,000	59,000	431,974	Oct 06 06:11 PM
Maag Peter	Chief Executive Officer	Oct 05	Sale	42.11	10,000	421,128	421,974	Oct 06 06:11 PM
Maag Peter	Chief Executive Officer	Oct 01	Option Exercise	5.67	20,000	113,351	441,974	Oct 02 06:26 PM
Maag Peter	Chief Executive Officer	Oct 01	Sale	40.50	20,000	809,972	421,974	Oct 02 06:26 PM
Maag Peter	Chief Executive Officer	Sep 30	Option Exercise	5.49	16,992	93,286	438,966	Sep 30 08:10 PM
Maag Peter	Chief Executive Officer	Sep 30	Sale	37.59	16,992	638,802	421,974	Sep 30 08:10 PM
Cohen Fred E	Director	Sep 21	Option Exercise	5.17	16,424	84,905	90,893	Sep 22 09:14 PM
Maag Peter	Chief Executive Officer	Sep 08	Option Exercise	5.49	10,000	54,900	431,974	Sep 08 05:46 PM
Maag Peter	Chief Executive Officer	Sep 08	Sale	31.68	9,900	313,609	422,074	Sep 08 05:46 PM
Maag Peter	Chief Executive Officer	Aug 05	Option Exercise	5.32	13,008	69,247	434,982	Aug 07 05:56 PM
Maag Peter	Chief Executive Officer	Aug 05	Sale	36.77	13,008	478,339	421,974	Aug 07 05:56 PM
Maag Peter	Chief Executive Officer	Jul 06	Option Exercise	4.00	10,000	39,951	431,974	Jul 07 09:25 PM
Maag Peter	Chief Executive Officer	Jul 06	Sale	34.21	10,000	342,098	421,974	Jul 07 09:25 PM
Maag Peter	Chief Executive Officer	Jun 30	Option Exercise	2.30	9,267	21,314	400,156	Jul 02 05:40 PM
Maag Peter	Chief Executive Officer	Jun 30	Sale	35.07	18,182	637,719	381,974	Jul 02 05:40 PM
Maag Peter	Chief Executive Officer	Jun 09	Sale	35.00	1,818	63,630	389,499	Jun 11 07:44 PM
Maag Peter	Chief Executive Officer	Jun 05	Sale	32.58	50,000	1,629,167	391,317	Jun 05 07:47 PM
King Sasha	Chief Commercial Officer	Jun 01	Sale	33.10	25,402	840,839	28,334	Jun 01 07:21 PM
Maag Peter	Chief Executive Officer	May 19	Sale	32.24	30,000	967,122	459,909	May 19 06:16 PM
Bickerstaff George	Director	May 13	Sale	27.65	10,000	276,458	85,657	May 13 05:28 PM
Goldberg Michael	Director	May 11	Sale	29.86	10,000	298,628	80,765	May 11 07:05 PM
HAGSTROM WILLIAM A	Director	May 06	Option Exercise	1.22	15,000	18,300	30,385	May 07 07:29 PM
Bell Michael Brian	Chief Financial Officer	May 06	Option Exercise	6.57	35,816	235,189	134,229	May 08 07:18 PM
HAGSTROM WILLIAM A	Director	May 06	Sale	29.12	15,000	436,829	15,385	May 07 07:29 PM
Bell Michael Brian	Chief Financial Officer	May 06	Sale	29.00	57,136	1,657,032	77,093	May 08 07:18 PM
Maag Peter	Chief Executive Officer	Mar 16	Sale	17.39	10,000	173,873	489,909	Mar 16 08:48 PM
SNYDERMAN RALPH	Director	Mar 03	Option Exercise	3.70	14,598	53,998	79,901	Mar 04 08:37 PM
Maag Peter	Chief Executive Officer	Feb 18	Sale	26.62	10,000	266,201	451,909	Feb 19 07:25 PM
King Sasha	Chief Commercial Officer	Feb 14	Sale	26.01	7,390	192,221	48,502	Feb 14 09:15 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience